TOPCAT Analysis: Spironolactone Benefits HFPEF in Americas TOPCAT Analysis: Spironolactone Benefits HFPEF in Americas

A new post hoc analysis questions whether many patients entered into the trial in Russia and Georgia actually had heart failure. Heartwire
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news